1 Oesophageal emptying of solids was studied with a scintigraphic technique in 12 patients with insulin dependent diabetes complicated by autonomic neuropathy and in 22 control subjects. 2 In the diabetics the acute and chronic effects of oral domperidone on oesophageal emptying and symptoms of heartburn and dysphagia were assessed. 3 The number of swallows required to clear the oesophagus in the diabetics (median 9.5, range 2-30) was significantly greater (P < 0.001) than in normal controls (median 2, range 1-14). 4 Domperidone did not increase solid oesophageal emptying in diabetic patients either after acute or after chronic administration.
Introduction Methods
Oesophageal motor dysfunction, characterised by a reduction in the primary peristaltic wave with frequent spontaneous contractions has been demonstrated in patients with diabetes mellitus by manometric and radiological techniques (Vix, 1969; Silber, 1969; Mandelstam et al., 1969; Vela & Balart, 1970; Horgan & Doyle, 1971; Stewart et al., 1976; Hollis et al., 1977) . Oesophageal dysfunction is relatively common in diabetes mellitus, may be asymptomatic and is often associated with peripheral neuropathy (Hollis et al., 1977) . The treatment of oesophageal disorders in diabetics is often unsatisfactory.
We have used a radionuclide technique to measure oesophageal emptying (Maddern et al., 1984) The solid bolus test has been reported previously (Maddern et al., 1984) . The bolus is prepared by cooking a 100 g mince beef 'hamburger' to which is added 1.6 mCi 9mTc macro-aggregated albumin. A 10 g disc is then cut from the 'hamburger'. The subject undergoes an overnight fast and is seated upright with the gamma camera positioned posteriorly. The subject swallows 5 ml of water following which the meat is chewed into a bolus. The subject is then asked to swallow the bolus and instructed to swallow every 15 s on command. Cricoid movement is monitored during the performance of the test to ensure that no additional swallows are taken. The test is continued until the bolus is seen to enter the stomach or until 30 swallows have been carried out.
Oesophageal emptying was measured once in each control subject. In each diabetic subject three oesophageal emptying tests were performed. Two initial oesophageal emptying tests were separated by a maximum period of 7 days. Recent evidence suggests that they are as sensitive as manometric techniques in detecting oesophageal dysfunction in diabetes mellitus (Russell et al., 1983) and other oesophageal motility disorders (Maddern et al., 1984; Tolin et al., 1979; Blackwell et al., 1983) . Our findings of a marked delay of oesophageal emptying in four of the 12 diabetics studied (of which two were asymptomatic) is consistent with this. The use of a solid food bolus may be more appropriate than liquid in the detection of clinically significant abnormalities of oesophageal emptying, as patients usually complain of solid food dysphagia. The aetiology of the oesophageal dysfunction in diabetes mellitus may be a vagal neuropathy (Hollis et al., 1977) . The use of prokinetic drugs such as metoclopramide and bethanechol in the treatment of disordered oesophageal motility (and the resulting delayed emptying) has been suggested and supported by objective evidence of increased contractile activity in the oesophagus after their administration (Hollis et al., 1977) . However although manometric studies may demonstrate objectively that increased motor activity occurs after such pharmacological intervention, this may not correlate with increased emptying.
Domperidone is a new gastrokinetic drug which is a potent peripheral dopamine antagonist like metoclopramide but lacks cholinergic activity and does not cross the blood-brain barrier, consequently neurological side effects are rare. Reports (Bron & Massih, 1980; Pozzessere et al., 1982; Brogden et al., 1982; Horowitz et al., 1984) have indicated that domperidone is effective in a variety of gastrointestinal disorders.
This study demonstrates that domperidone does not improve oesophageal emptying of a solid bolus in a group of patients with diabetic autonomic neuropathy. Four of the 12 patients studied had oesophageal emptying values outside the normal range on the placebo test and in all of these oesophageal emptying was unchanged after acute administration of domperidone. It therefore appears unlikely that domperidone will increase oesophageal emptying of a solid bolus in diabetic patients with either clearly abnormal or normal oesophageal function. Our results show a trend towards improve- in the symptoms of heartburn and dysphagia after treatment, but the number of patients is small, the changes are not statistically significant and a placebo control was not included. The same dose of oral domperidone has previously been demonstrated by our group to increase both solid and liquid gastric emptying in these patients . It therefore appears likely that the oesophageal emptying disorder in diabetics is more resistant to treatment with prokinetic drugs than delayed gastric emptying.
